vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $148.3M, roughly 1.3× Shoals Technologies Group, Inc.). Shoals Technologies Group, Inc. runs the higher net margin — 5.5% vs -14.6%, a 20.0% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 38.6%). Shoals Technologies Group, Inc. produced more free cash flow last quarter ($-11.3M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 27.8%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.
AXSM vs SHLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $148.3M |
| Net Profit | $-28.6M | $8.1M |
| Gross Margin | — | 31.6% |
| Operating Margin | -13.8% | 11.7% |
| Net Margin | -14.6% | 5.5% |
| Revenue YoY | 65.0% | 38.6% |
| Net Profit YoY | 61.9% | 3.9% |
| EPS (diluted) | $-0.55 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $148.3M | ||
| Q3 25 | $171.0M | $135.8M | ||
| Q2 25 | $150.0M | $110.8M | ||
| Q1 25 | $121.5M | $80.4M | ||
| Q4 24 | $118.8M | $107.0M | ||
| Q3 24 | $104.8M | $102.2M | ||
| Q2 24 | $87.2M | $99.2M | ||
| Q1 24 | $75.0M | $90.8M |
| Q4 25 | $-28.6M | $8.1M | ||
| Q3 25 | $-47.2M | $11.9M | ||
| Q2 25 | $-48.0M | $13.9M | ||
| Q1 25 | $-59.4M | $-282.0K | ||
| Q4 24 | $-74.9M | $7.8M | ||
| Q3 24 | $-64.6M | $-267.0K | ||
| Q2 24 | $-79.3M | $11.8M | ||
| Q1 24 | $-68.4M | $4.8M |
| Q4 25 | — | 31.6% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 37.2% | ||
| Q1 25 | — | 35.0% | ||
| Q4 24 | — | 37.6% | ||
| Q3 24 | — | 24.8% | ||
| Q2 24 | — | 40.3% | ||
| Q1 24 | — | 40.2% |
| Q4 25 | -13.8% | 11.7% | ||
| Q3 25 | -27.0% | 13.7% | ||
| Q2 25 | -24.5% | 14.4% | ||
| Q1 25 | -46.9% | 5.4% | ||
| Q4 24 | -61.1% | 15.4% | ||
| Q3 24 | -59.8% | 4.4% | ||
| Q2 24 | -89.5% | 18.7% | ||
| Q1 24 | -89.7% | 12.8% |
| Q4 25 | -14.6% | 5.5% | ||
| Q3 25 | -27.6% | 8.7% | ||
| Q2 25 | -32.0% | 12.5% | ||
| Q1 25 | -48.9% | -0.4% | ||
| Q4 24 | -63.1% | 7.3% | ||
| Q3 24 | -61.7% | -0.3% | ||
| Q2 24 | -91.0% | 11.9% | ||
| Q1 24 | -91.1% | 5.3% |
| Q4 25 | $-0.55 | $0.05 | ||
| Q3 25 | $-0.94 | $0.07 | ||
| Q2 25 | $-0.97 | $0.08 | ||
| Q1 25 | $-1.22 | $0.00 | ||
| Q4 24 | $-1.54 | $0.04 | ||
| Q3 24 | $-1.34 | $0.00 | ||
| Q2 24 | $-1.67 | $0.07 | ||
| Q1 24 | $-1.44 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $7.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $600.0M |
| Total Assets | $689.8M | $904.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $7.3M | ||
| Q3 25 | $325.3M | $8.6M | ||
| Q2 25 | $303.0M | $4.7M | ||
| Q1 25 | $300.9M | $35.6M | ||
| Q4 24 | $315.4M | $23.5M | ||
| Q3 24 | $327.3M | $11.1M | ||
| Q2 24 | $315.7M | $3.2M | ||
| Q1 24 | $331.4M | $15.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $141.8M | ||
| Q4 24 | — | $141.8M | ||
| Q3 24 | — | $141.8M | ||
| Q2 24 | — | $146.8M | ||
| Q1 24 | — | $168.8M |
| Q4 25 | $88.3M | $600.0M | ||
| Q3 25 | $73.7M | $589.6M | ||
| Q2 25 | $73.1M | $575.4M | ||
| Q1 25 | $53.2M | $558.9M | ||
| Q4 24 | $57.0M | $556.8M | ||
| Q3 24 | $92.9M | $545.2M | ||
| Q2 24 | $102.9M | $544.6M | ||
| Q1 24 | $144.0M | $554.0M |
| Q4 25 | $689.8M | $904.1M | ||
| Q3 25 | $669.3M | $851.8M | ||
| Q2 25 | $639.8M | $795.0M | ||
| Q1 25 | $596.7M | $788.4M | ||
| Q4 24 | $568.5M | $793.1M | ||
| Q3 24 | $561.5M | $801.3M | ||
| Q2 24 | $548.2M | $788.4M | ||
| Q1 24 | $545.7M | $825.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.30× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $-4.1M |
| Free Cash FlowOCF − Capex | $-18.7M | $-11.3M |
| FCF MarginFCF / Revenue | -9.6% | -7.6% |
| Capex IntensityCapex / Revenue | 0.0% | 4.8% |
| Cash ConversionOCF / Net Profit | — | -0.50× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $-4.1M | ||
| Q3 25 | $1.0M | $19.4M | ||
| Q2 25 | $-32.4M | $-13.8M | ||
| Q1 25 | $-43.4M | $15.6M | ||
| Q4 24 | $-26.2M | $14.0M | ||
| Q3 24 | $-18.6M | $15.7M | ||
| Q2 24 | $-30.1M | $37.8M | ||
| Q1 24 | $-53.5M | $12.9M |
| Q4 25 | $-18.7M | $-11.3M | ||
| Q3 25 | $988.0K | $9.0M | ||
| Q2 25 | $-32.4M | $-26.0M | ||
| Q1 25 | $-43.7M | $12.3M | ||
| Q4 24 | $-26.2M | $12.5M | ||
| Q3 24 | $-18.7M | $13.3M | ||
| Q2 24 | $-30.2M | $35.8M | ||
| Q1 24 | $-53.6M | $10.4M |
| Q4 25 | -9.6% | -7.6% | ||
| Q3 25 | 0.6% | 6.6% | ||
| Q2 25 | -21.6% | -23.5% | ||
| Q1 25 | -36.0% | 15.4% | ||
| Q4 24 | -22.1% | 11.6% | ||
| Q3 24 | -17.9% | 13.0% | ||
| Q2 24 | -34.6% | 36.1% | ||
| Q1 24 | -71.4% | 11.4% |
| Q4 25 | 0.0% | 4.8% | ||
| Q3 25 | 0.0% | 7.7% | ||
| Q2 25 | 0.0% | 11.0% | ||
| Q1 25 | 0.3% | 4.0% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.1% | 2.3% | ||
| Q2 24 | 0.1% | 2.0% | ||
| Q1 24 | 0.1% | 2.7% |
| Q4 25 | — | -0.50× | ||
| Q3 25 | — | 1.63× | ||
| Q2 25 | — | -1.00× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.21× | ||
| Q1 24 | — | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
SHLS
| System Solutions | $122.0M | 82% |
| Components | $26.3M | 18% |
